ImpediMed Limited (ASX: IPD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ImpediMed Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ImpediMed Limited (ASX: IPD)
Latest News
Share Market News
Impedimed (ASX:IPD) share price bounces on 'significant' hospital finding
Share Market News
The Impedimed (ASX:IPD) share price rocketed 13% today. Here's why
Share Market News
Why the Impedimed (ASX:IPD) share price shot higher this morning
Share Market News
Why the Impedimed (ASX:IPD) share price will be on watch today
Share Market News
Here's why the Impedimed (ASX:IPD) share price shot up 13% today
Share Market News
Fund managers have been buying these ASX shares this week
Share Gainers
These ASX small cap shares posted strong gains today
⏸️ Growth Investing
There 3 under-the-radar healthcare shares could make you rich
⏸️ Investing
3 shares helping people get better and richer
⏸️ Investing
Is this medical device stock the next to surge after Cochlear Limited and ResMed Inc.?
⏸️ Investing
Why these 4 ASX shares have started the week with a bang
⏸️ Investing
Why these 4 ASX shares have posted strong gains today
Frequently Asked Questions
-
No, Impedimed does not pay shareholder dividends at this time.
-
Impedimed Limited listed on the ASX on 24 October 2007.
IPD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ImpediMed Limited
Impedimed Ltd (ASX: IPD) is a global leader in the design and manufacture of medical devices that use bioimpedance spectroscopy (BIS) technologies in the non-invasive clinical assessment of fluid and tissue composition.
The company's products are typically used to assess and monitor lymphedema and heart failure, as well as to measure patients' tissue composition and fluid status. They also have general health applications in weight management, nutritional issues, and assessing bone content.
As well, Impedimed offers a cloud-based digital platform to manage patient data. The company is based in Australia and generates most of its revenue in North America.
